Dr. Reddy's Laboratories announced on Thursday that the Mexican drug regulatory authority has imposed a penalty of approximately Rs 28 lakh (MXN 6,51,420).
This penalty was levied due to the company's deviation from established guidelines regarding the notification of the import of a reference standard for one of its active pharmaceutical ingredients, as stated in a regulatory filing by the Hyderabad-based firm.
Despite this development, shares of Dr. Reddy's were trading up by 0.39% at Rs 6,720 per share on the BSE.
(With PTI Inputs)
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
